Trendlines slips below the line on debut
Singapore
THE trading debut of Trendlines Group, an Israeli biomed incubator, on the Catalist board may be worthy of celebration for several reasons but its shabby stock performance on Thursday belied that.
Trendlines is the 100th firm to seek a new listing on Catalist since the junior board was launched eight years ago and it also marks the first listing of an Israeli firm on SGX in a decade.
TRENDING NOW
‘So little’?: Why critics of Temasek’s 10.5% returns in a bull run are getting it wrong
OpenAI unveils long-awaited “super app” as rivalry with Anthropic intensifies
New MAS proposal could pave way for commodity futures funds, more single-country bond funds for retail investors
Stocks to watch: China Aviation Oil, Marco Polo Marine, Foundation Healthcare